tiprankstipranks
Trending News
More News >
SinoMab Bioscience Ltd. (HK:3681)
:3681
Hong Kong Market

Compare SinoMab Bioscience Ltd. (3681) vs. Competitors

Compare
1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
SinoMab Bioscience Ltd.
HK$1.39
HK$2.35B
-11.90
72.73%
RemeGen Co. Ltd. Class H
HK$94.65
HK$57.70B
-50.14
680.94%
4 Buy
3 Hold
0 Sell
Moderate Buy
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$25.16
HK$40.05B
-24.53
134.70%
0 Buy
1 Hold
1 Sell
Moderate Sell
Lepu Biopharma Co. Ltd. Class H
HK$4.98
HK$9.91B
-47.34
123.11%
1 Buy
0 Hold
0 Sell
Moderate Buy
Jiangsu Recbio Technology Co., Ltd. Class H
HK$4.18
HK$1.90B
-2.69
-52.12%
Shanghai Henlius Biotech, Inc. Class H
HK$58.60
HK$36.41B
40.91
183.90%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:3681
SinoMab Bioscience Ltd.
1.71
0.71
71.00%
HK:9995
RemeGen Co. Ltd. Class H
94.65
82.57
683.53%
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
25.16
14.68
140.08%
HK:2157
Lepu Biopharma Co. Ltd. Class H
5.33
3.06
134.80%
HK:2179
Jiangsu Recbio Technology Co., Ltd. Class H
3.96
-4.31
-52.12%
HK:2696
Shanghai Henlius Biotech, Inc. Class H
67.00
44.50
197.78%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts